BioSpace1d
FDA Committee Calls For More Research After Moderna’s RSV Vaccine Safety Issues
Following news of RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines, ...
FiercePharma1d
After Moderna's pediatric RSV vaccine trial hold, expert panel says more testing is needed
Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that ...
Moderna Inc. stock outperforms competitors despite losses on the day
Moderna Inc. closed $127.65 below its 52-week high ($170.47), which the company achieved on May 24th.
Hosted on MSN17h
Palantir, MicroStrategy, Axon Join Nasdaq 100; Moderna, Super Micro Get The Axe
Palantir and bitcoin play MicroStrategy are expected to get a Nasdaq 100 index invite Friday. Will Moderna and Super Micro ...
The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind
In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely to thrive the uncharted waters that were rising all around us. The early ...
News Nation on MSN14h
Soldier injured by COVID vaccine: ‘I contemplated suicide’
Stancik, 24, said she was "abandoned by the military" after suffering three heart attacks and a stroke after receiving the ...
bovnews1d
The Moderna Inc Enigma: What’s Causing the Wild Swings in MRNA Stock?
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 10.82% ...
Yahoo1d
FDA panel seeks more data on RSV vaccine safety in infants
The advisory committee, which met at the FDA’s request Thursday, did not reach a conclusion about the cause of a safety ...
Unpacking the Latest Options Trading Trends in Moderna
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
Palantir, MicroStrategy, and Axon Enterprise To Join Nasdaq 100
Palantir, MicroStrategy, and Axon Enterprise are set to join the Nasdaq 100 Index on Monday, Dec. 23, replacing Super Micro ...
bovnews2d
Moderna Inc (MRNA) Stock Price Reaches $41.51: What Factors Are Influencing This Level?
On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $41.51 which represents a decrease of $-4.14 or -9.07% from the prior close of $45.65. The stock opened at $45.36 and touched a ...